Compare FLGT & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLGT | VREX |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.3M | 501.8M |
| IPO Year | 2016 | 2016 |
| Metric | FLGT | VREX |
|---|---|---|
| Price | $18.42 | $10.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $28.33 | $16.67 |
| AVG Volume (30 Days) | ★ 515.6K | 477.8K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,730,000.00 | ★ $811,000,000.00 |
| Revenue This Year | $10.09 | $5.35 |
| Revenue Next Year | $12.18 | $3.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.46 | $6.76 |
| 52 Week High | $31.04 | $14.57 |
| Indicator | FLGT | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 42.87 |
| Support Level | $13.91 | $9.81 |
| Resistance Level | $22.66 | $12.60 |
| Average True Range (ATR) | 0.67 | 0.44 |
| MACD | 0.25 | 0.05 |
| Stochastic Oscillator | 92.23 | 51.34 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.